{
    "nctId": "NCT05223218",
    "briefTitle": "Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study",
    "officialTitle": "Investigating the Diagnostic Potential of Tear Proteins in Breast, Ovarian, Prostate, Melanoma, Pancreatic, and Colon Cancer",
    "overallStatus": "ENROLLING_BY_INVITATION",
    "conditions": "Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer, Melanoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "Identify Cancer-related Biomarkers",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18-100 years of age\n* Presenting for the evaluation of an abnormal exam or test (mammogram, ultrasound, MRI, PET, etc.)\n* Presenting for the evaluation of a palpable lump or mass\n* Presenting with a mass may be pre or post-biopsy/diagnostic as long as there is a portion of the mass remaining.\n* Have been diagnosed but have not received treatment\n\nExclusion Criteria:\n\n* Less than 18 years of age OR more than 100 years of age\n* Concurrent eye infection or trauma\n* Acute conjunctivitis",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}